Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1070 results about "Succinic acid" patented technology

Succinic acid (/səkˈsɪnɪk/) is a dicarboxylic acid with the chemical formula (CH₂)₂(CO₂H)₂. The name derives from Latin succinum, meaning amber. In living organisms, succinic acid takes the form of an anion, succinate, which has multiple biological roles as a metabolic intermediate being converted into fumarate by the enzyme succinate dehydrogenase in complex 2 of the electron transport chain which is involved in making ATP, and as a signaling molecule reflecting the cellular metabolic state. It is marketed as food additive E363. Succinate is generated in mitochondria via the tricarboxylic acid cycle (TCA). Succinate can exit the mitochondrial matrix and function in the cytoplasm as well as the extracellular space, changing gene expression patterns, modulating epigenetic landscape or demonstrating hormone-like signaling. As such, succinate links cellular metabolism, especially ATP formation, to the regulation of cellular function. Dysregulation of succinate synthesis, and therefore ATP synthesis, happens in some genetic mitochondrial diseases, such as Leigh syndrome, and Melas syndrome, and degradation can lead to pathological conditions, such as malignant transformation, inflammation and tissue injury.

Washable semiconductor solder paste and preparation method and application thereof

The invention relates to the technical field of welding materials, and discloses washable semiconductor solder paste and a preparation method and application thereof. The washable semiconductor solder paste comprises scaling powder and tin powder, wherein the mass ratio of the scaling powder to the tin powder is 1: (8-9.6); the soldering flux comprises the following raw material components: a film-forming agent, composite organic acid, a thixotropic agent, a surfactant, an antioxidant and a solvent, wherein the composite organic acid is composed of succinic acid and glutaric acid according to the mass ratio of (1-3): (1-2.5). According to the washable semiconductor solder paste, the particle size, the melting point and the alloy components of the tin powder are controlled, composite organic acid composed of succinic acid and glutaric acid in a specific proportion is adopted in the soldering flux, and other components are matched with one another; the tin powder and the soldering flux in a specific mass ratio are combined, so that the prepared washable semiconductor solder paste is good in wettability, the expansion rate is larger than or equal to 85%, the storage life reaches 3 months, and the washable semiconductor solder paste can be directly cleaned with water after being welded and is high in corrosion resistance and oxidation resistance.
Owner:DONGGUAN GAOHAILIANG METAL MATERIAL TECH CO LTD

Moisturizing contact lens containing hyaluronic acid coating and preparation method thereof

The invention belongs to the technical field of contact lenses, and provides a moisturizing contact lens containing a hyaluronic acid coating and a preparation method of the moisturizing contact lens. The preparation method comprises the following steps: carrying out ultrasonic mixing on a hydrophilic monomer, a siloxane monomer, a cross-linking agent and an initiator, injecting the mixed solution into a contact lens mold, and carrying out polymerization reaction to obtain a contact lens material; mixing the chitosan solution, the shellac acid solution, the hyaluronic acid solution and the vitamin E succinate solution to obtain a hyaluronic acid mixed solution; and soaking the contact lens material in the hyaluronic acid mixed solution, adding a cross-linking agent, curing, and drying to obtain the moisturizing contact lens containing the hyaluronic acid coating. The contact lens disclosed by the invention has excellent moisture retention, good light transmission performance, swelling performance and excellent mechanical property, the wearing comfort is remarkably improved, and the contact lens is suitable for being worn for a long time; the preparation method disclosed by the invention is environment-friendly and easy to industrialize.
Owner:GANSU TIANHOU OPTICAL TECHNOLOGY CO LTD

An engineered bacterium with high yield of observation blue and a construction method and application thereof

The application relates to an engineering bacterium for high yield of observation blue and a construction method and application thereof, and belongs to the technical field of biological synthesis of natural dyes. The engineering bacterium for high yield of observation blue expresses icd, bpsA, glnA Y405F and gdhA; the engineering bacterium knocks out acnR, yggB, glsK, aceA and ldh. By knocking out the yggB and aceA genes, performing site-directed mutation (Y405F) on the glnA gene, replacing the glsK gene with the glnA Y405F gene, replacing the acnR gene with the icd gene, replacing the ldh gene with the gdhA gene, and integrating the bpsA gene, the application can block the formation of by-products such as lactate and succinic acid in the observation blue synthesis process, improve the flow direction of the citric acid->isocitric acid->alpha-ketoglutaric acid->glutamic acid->glutamine path, and then improve the intracellular glutamine concentration, so that the yield of observation blue is improved.
Owner:VERTEXYN (NANJING) BIOWORKS CO LTD

Rapid fluorescence detection of drug resistance of botrytis cinerea to succinate dehydrogenase bactericides based on RPA-CRISPR / Cas12a

The invention discloses a method for detecting drug resistance of botrytis cinerea to succinate dehydrogenase (SDHI) bactericides. On the basis of an RPA-CRISPR / Cas12a system, a specific primer pair amplification target fragment and crRNA for activating Cas12a trans-cleavage activity are designed aiming at key mutation sites related to drug resistance in a bactericide action target SdhB gene, so that fluorescent light visible to naked eyes can be generated only when a resistant strain sequence is matched with the crRNA, and the fluorescent light is opposite to the fluorescent light generated when a sensitive strain sequence is matched with the crRNA. The method provided by the invention overcomes the dependence on laboratories and large instruments in the traditional drug resistance detection method, provides key technical support for accurate prevention and control and drug resistance management of grape gray mold, and provides direct drug use basis for scientific prevention and control in the field.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

Preparation method of double embedded emulsion preparation / emulsion based on cyclodextrin octenylsuccinate

The invention discloses a preparation method of a double embedding emulsion preparation / emulsion based on octenyl succinic acid cyclodextrin ester, and relates to an inclusion compound based on modified cyclodextrin and a stable Pickering emulsion system thereof. According to the method, the uniformity of the cyclodextrin modification substitution degree is improved through ultrasonic assistance, the embedding rate and the embedding stability of hydrophobic active ingredients can be improved, meanwhile, the Pickering emulsion is stabilized, preparation of the double-embedded emulsion preparation is achieved, and the stability and the packaging efficiency of an emulsion preparation packaging delivery system can be effectively improved through the method. The method comprises the following steps: 1, preparing octenyl succinic acid cyclodextrin ester; 2, preparing an OSA-beta-CD / phenolic compound clathrate compound; and 3, preparing the dual-embedding emulsion preparation / emulsion. The invention provides a preparation method of a double-embedding emulsion preparation / emulsion based on octenyl succinic acid cyclodextrin ester. The double-embedding emulsion preparation / emulsion can be applied to a double-embedding food functional component delivery system.
Owner:HARBIN UNIV OF COMMERCE

Oil-control acne-removal synergistic composition, sustained-release body, and preparation method and application of oil-control acne-removal synergistic composition and sustained-release body

The invention discloses an oil-controlling and acne-removing synergistic composition which comprises the following components in percentage by weight: 0.8 to 2.0 percent of succinic acid, 0.3 to 1.0 percent of salicylic acid derivative and 0.5 to 1.5 percent of PCA (Principal Component Analysis) zinc. The invention also provides a sustained-release body. The sustained-release body is prepared from the following components in percentage by weight: 0.8 to 2.0 percent of succinic acid, 0.3 to 1.0 percent of salicylic acid derivative, 0.5 to 1.5 percent of PCA zinc, 1.0 to 2.5 percent of lactobionic acid, 1.0 to 3.0 percent of lactobacillus fermentation product, 2.0 to 4.0 percent of aminated modified diatomite and 0.1 to 0.3 percent of citric acid. The invention also provides a preparation method and application of the sustained release body. The acne-removing shampoo has low irritation, and can be used for controlling oil and removing acnes for a long time and efficiently dredging hair follicles.
Owner:GUANGDONG PINSHENG BIOTECHNOLOGY CO LTD

Preparation method of liposome for encapsulating euphausia superba oil

The invention discloses a preparation method of liposome for encapsulating euphausia superba oil, and belongs to the field of euphausia superba oil. Through material selection and hierarchical structure design, starch octenyl succinate, sodium alginate and pea protein are screened as composite wall materials, and the materials can achieve a synergistic effect on the molecule-interface-micro-nano scale to delay lipid oxidation, control the targeted release characteristic of active ingredients and improve the absorption efficiency of fat-soluble ingredients. Moreover, the liposome raw material of the euphausia superba oil is screened, and the liposome with low particle size and high stability is prepared.
Owner:JIANGNAN UNIV +1

Betaine succinate eutectic crystal and preparation method and application thereof

The invention provides a betaine succinate eutectic crystal as well as a preparation method and application thereof, and belongs to the technical field of eutectic crystal manufacturing. The structural formula of the succinic acid betaine eutectic crystal is shown as a formula I, the molecular formula of the succinic acid betaine eutectic crystal is C28H56N4O16, in the succinic acid betaine eutectic crystal, the molar ratio of succinic acid to betaine is 1: 2, and the succinic acid betaine eutectic crystal has low irritation and excellent effects.
Owner:PROYA COSMETICS CO LTD +1

Linkers

The present invention relates to linkers for connecting a carrier molecule to a therapeutic molecule to form a conjugate, in particular linkers formed of amino acids such as glutamic acid, succinic acid, and gamma-aminobutyric acid. The present invention further relates to a conjugate comprising a linker of the invention, and the use of the conjugate in the treatment of various diseases.
Owner:OXFORD UNIVERSITY INNOVATION LTD +1

Polyethylene glycol derivative-collagen injectable cartilage repair gel as well as preparation method and application thereof

The invention provides a polyethylene glycol derivative-collagen cartilage repair gel which is characterized by being prepared from the following components in parts by weight: 8 to 12 parts of collagen (namely COL) solution, 0.5 to 2 parts of polydeoxyribonucleotide (namely PDRN), 4 to 8 parts of polyethylene glycol disuccinimide succinate (namely SS-PEG-SS) solution and 0.1 to 0.4 part of tannic acid (namely TA), and particularly discloses a preparation method and application of the polyethylene glycol derivative-collagen cartilage repair gel. In a word, the composite gel and the collagen are subjected to efficient amidation reaction through SS-PEG-SS to form a stable three-dimensional network, so that the structural support of the type I collagen, the tissue repair of PDRN and the anti-inflammatory and anti-oxidation characteristics of tannic acid are successfully integrated; therefore, the composite material has the comprehensive performance of good structural stability, high mechanical strength, good biocompatibility, controllable degradation period, excellent needle passing performance and the like, and shows the wide application prospects of clear repair effect, remarkable component synergistic effect, mature production process, outstanding cost effectiveness and the like.
Owner:BEIJING UNIV OF CHEM TECH

High-selectivity flotation method for micro-fine particle mica containing rubidium, cesium and lithium

The invention provides a high-selectivity flotation method for micro-fine particle lepidolite containing rubidium and cesium, which comprises the following steps: levigating raw lepidolite ore, and desliming to obtain a flotation material and slime; adding sodium hexametaphosphate and a collecting agent HT8-01 into the flotation material, stirring, and roughing to obtain lepidolite rough concentrate and flotation tailings I; a collecting agent HT8-01 is added into the flotation tailings I for two times of scavenging, flotation tailings and two scavenging middlings are obtained, and the scavenging middlings are sequentially returned to the upper layer for operation; sodium hexametaphosphate is added into the lepidolite rough concentrate for two times of concentration, lepidolite concentrate and two concentrated middlings are obtained, and the concentrated middlings are sequentially returned to the upper layer for operation; the collecting agent HT8-01 is obtained by mixing octadecylamine and sodium dioctyl sulfosuccinate according to the mass ratio of 5: 3. According to the method, the separation effect of the rubidium-cesium-lithium-containing mica and gangue minerals such as quartz and feldspar is improved, the problems that foam is too stable, the viscosity is too high and the size is too large are solved, and high-selectivity separation of the micro-fine-particle rubidium-cesium-lithium-containing mica is achieved.
Owner:JIANGXI UNIV OF SCI & TECH

Epoxidized soybean oil-binary acid bio-based dynamic polymer, preparation method thereof and paper-based strain sensor packaged by epoxidized soybean oil-binary acid bio-based dynamic polymer

The invention provides an epoxidized soybean oil-binary acid bio-based dynamic polymer, a preparation method thereof and a paper-based strain sensor packaged by the epoxidized soybean oil-binary acid bio-based dynamic polymer. The preparation method of the dynamic polymer comprises the following steps: (1) taking epoxidized soybean oil as an epoxy monomer, aliphatic dibasic acid as a flexible monomer and aromatic dibasic acid as a rigid monomer, and carrying out polymerization reaction in the presence of a transesterification catalyst to obtain a dynamic polymer prepolymer; the aliphatic binary acid comprises succinic acid, adipic acid and sebacic acid; (2) removing bubbles from the dynamic polymer prepolymer; and (3) carrying out thermal curing on the dynamic polymer prepolymer to obtain the epoxidized soybean oil-binary acid bio-based dynamic polymer. The epoxidized soybean oil-binary acid bio-based dynamic polymer has good mechanical properties and hydrophobicity, a paper-based strain sensor based on the epoxidized soybean oil-binary acid bio-based dynamic polymer also has good mechanical properties and hydrophobicity, and the sensor has certain application potential in the field of human motion monitoring.
Owner:SHAANXI UNIV OF SCI & TECH

High-strength starch sodium octenylsuccinate gel and preparation method thereof

The invention belongs to the technical field of gel. The invention provides high-strength starch sodium octenylsuccinate gel and a preparation method thereof.The preparation method comprises the steps that S1, corn and cassava starch are mixed according to the mass ratio of 1: (4.4-4.6) to obtain a mixture, and then the mixture and soft water are dispersed according to the mass ratio of 1: 1.1 to obtain starch milk; s2, adjusting the pH value of the starch milk to 9.0 by using a sodium hydroxide solution, then adding octenyl succinic anhydride at 25 DEG C, then adding sucrose ester and pectin, neutralizing the pH value to 4.5 by using an HC1 solution, and carrying out suction filtration, washing and crushing to obtain starch sodium octenyl succinate powder; and S3, gelatinizing the starch sodium octenylsuccinate powder, and storing the gelatinized starch sodium octenylsuccinate powder at low temperature to obtain the high-strength starch sodium octenylsuccinate gel. According to the invention, by reducing the ratio of corn starch to cassava starch, the viscosity of the prepared starch sodium octenylsuccinate is further improved while a lower gelatinization temperature is ensured.
Owner:HANGZHOU RUILIN CHEM IND CO LTD

Solid dispersion-based sustained-release drug composite carrier as well as preparation method and application thereof

The invention relates to the technical field of pharmaceutical preparations, in particular to a solid dispersion-based sustained-release drug composite carrier as well as a preparation method and application thereof. The preparation method comprises the following steps: carrying out synergistic spray drying on double polymers (hydroxypropyl methylcellulose acetate succinate and polyvinylpyrrolidone-vinyl acetate copolymer) to form a solid dispersion; compounding with mesoporous silica and calcium silicate for localization, and spraying ethanol to activate pores; calcium stearate and magnesium stearate are sequentially added for lubrication; prefabricating a sustained-release skeleton master batch; and finally, mixing, rolling and forming. According to the method, through hierarchical structural design, the drug stability, the powder fluidity and the release controllability are remarkably improved, the method is suitable for industrial production of the dihydroergoline mesylate sustained release preparation, and a release curve is smooth and reliable.
Owner:宝利化(南京)制药有限公司

1-amino-1-cyclopropanecarboxylic acid solid compositions

The present invention is directed to a water-soluble granule compositions comprising 1-amino-1-cyclopropanecarboxylic acid (“ACC”), a filler selected from the group consisting of lactose, dextrose, sucrose or a mixture thereof, one or more wetting agents selected from the group consisting of a non-ionic ethoxylated sorbitan, a polyoxyethylene glycol alkyl ether and an anionic dioctyl sulfosuccinate, one or more binders selected from the group consisting of polyvinylpyrrolidone and a lignosulfonate and one or more organosilicon surfactants selected from the group consisting of a polyalkyleneoxide modified heptamethyltrisiloxane and a polyether trisiloxane.
Owner:VALENT BIOSCIENCES CORP

Pterostilbene-based stability enhanced antioxidant as well as preparation method and application thereof

The invention relates to the technical field of functional antioxidants, in particular to a stability-enhanced antioxidant based on pterostilbene and a preparation method and application thereof. The pterostilbene tablet comprises the following components in percentage by weight: 10-30% of pterostilbene, 8-20% of Arabic gum, 5-15% of tocopheryl succinate, 1-5% of disodium ethylene diamine tetraacetate, 30-60% of beta-cyclodextrin, 2-8% of rosmarinic acid, 1-6% of chitosan quaternary ammonium salt, 0.5-3% of nano silicon dioxide and 2-7% of polyglycerol fatty acid ester. In the preparation process, beta-cyclodextrin and pterostilbene form an inclusion compound, the dispersity of nano silicon dioxide and chitosan quaternary ammonium salt is improved through hydrogen bonds, and tea polyphenol or ascorbyl palmitate can be added to enhance the synergistic effect. The antioxidant is high in stability, high in pterostilbene retention rate, uniform in dispersion, free of agglomeration, excellent in antioxidant activity, suitable for the fields of foods, cosmetics and medicines, simple in preparation process, low in consumption and suitable for industrial production.
Owner:WANG SHUHE BIOMEDICINE (WUHAN) CO LTD

Biomarkers and use thereof for diagnosis, prevention, and treatment of muscle atrophy

There is provided a method for diagnosing a subject with early onset muscle atrophy, said method comprising: obtaining a biosample from the subject; and assaying the biosample for one or more biomarkers, said one more biomarkers are taurine, proline, citrulline, trigonelline, thymidine, ornithine, glutamate, L-pyroglutamic acid, creatinine, adenine, nicotinamide, 2-methylhippuric acid, maltol, L-arginine, hypotaurine, L-glutamine, homogentisic acid, methylhistidine, oxoglutaric acid, xanthine, L-carnitine, succinate, or a combination thereof; and identifying the subject with early onset muscle atrophy on the basis of a deviation in the one or more of said one more biomarkers.
Owner:MYOMAR MOLECULAR INC

Amorphous tigorazan tablet and preparation method thereof

The invention relates to the field of pharmaceutical preparations, and particularly discloses an amorphous-state tigorazan tablet and a preparation method thereof. The amorphous-state tigorazan tablet comprises a tablet and a coating material in a weight ratio of 100: (2-4), the tablet comprises the following raw materials: amorphous-state tigorazan, a carrier inclusion material, an excipient, a disintegrating agent, a lubricant and a flow aid, the dosage of the amorphous-state tigorazan is 20-30% of the total mass of all the raw materials of the tablet, and the dosage of the carrier inclusion material is 20-30% of the total mass of all the raw materials of the tablet. The weight ratio of the amorphous tigoran to the carrier inclusion material is 1: (0.80-1.15), and the carrier inclusion material is vitamin E polyethylene glycol succinate. The amorphous tigorazan tablet provided by the invention not only has higher solubility and dissolution rate, but also has higher stability and better hardness and friability, not only improves the bioavailability of drugs, but also avoids the use of organic solvents, simplifies the production process, reduces the risks of production safety and environmental protection, and is suitable for large-scale industrial production.
Owner:NINGBO MENOVO TIANKANG PHARMA CO LTD

Microcapsule powder capable of covering oil smell of euphausia superba and preparation method of microcapsule powder

The invention discloses microcapsule powder for covering the oil smell of euphausia superba oil and a preparation method of the microcapsule powder, and belongs to the field of euphausia superba oil processing. The microcapsule powder is composed of 50-75% of OSA starch, 10-30% of euphausia superba oil, 3-20% of sodium alginate, 1-10% of succinic acid and 0.5-5% of calcium hydrophosphate, during preparation, the OSA starch is gelatinized and then sheared and homogenized with the euphausia superba oil to obtain a miniemulsion, the succinic acid, the sodium alginate and the calcium hydrophosphate are prepared into a mixed solution, the mixed solution is mixed with the miniemulsion in proportion, and spray drying is performed to obtain a finished product. An OSA starch-sodium alginate double-wall material system is adopted, a compact cross-linked layer is formed through pH response, peculiar smell substances such as trimethylamine can be completely masked, the astaxanthin retention rate is up to 95.14%, the embedding rate reaches 89.48%, krill oil oxidation is effectively inhibited, krill oil is converted into powder, the stability and the sensory property are improved, application of krill oil in the food field is widened, the technology is simple, and the method is suitable for industrial production. The method is suitable for industrial production.
Owner:JIANGNAN UNIV

Method for separating and extracting bio-based succinic acid from fermentation liquor

The invention provides a method for separating and extracting bio-based succinic acid from fermentation liquor, which comprises the following steps: (1) enabling the fermentation liquor to sequentially pass through a ceramic membrane and a nanofiltration membrane, and decoloring to obtain bio-based succinic acid decolored liquor; (2) sequentially carrying out ion exchange impurity removal and concentration treatment on the bio-based succinic acid decoloring solution to obtain a bio-based succinic acid concentrated solution; and (3) carrying out multi-stage cooling crystallization on the bio-based succinic acid concentrated solution to obtain the bio-based succinic acid, the multi-stage cooling crystallization comprises first-stage crystallization, second-stage crystallization and third-stage crystallization which are carried out in sequence. Through the steps of integrated membrane filtration, decoloration, ion exchange, concentration, multi-stage crystallization and the like, thalli, proteins, pigments, inorganic ions and other impurities in fermentation liquor can be efficiently removed, so that a high-purity bio-based succinic acid product is obtained, meanwhile, the product yield is increased, and energy consumption and waste discharge are reduced.
Owner:KINGFA SCI & TECH CO LTD +2

A pH-sensitive curcumin nanoliposome, its preparation method and uses

This invention discloses a pH-sensitive curcumin nanoliposome, its preparation method, and its applications. The preparation method includes the following steps: dissolving 1,2-dioleoyl-SN-glycerol-3-phosphoethanolamine, cholesterol succinate monoester, cholesterol, pH-sensitive material, and curcumin in an alcohol solvent to obtain an inner-phase alcohol solution; dissolving a lyophilization protectant in water to obtain an outer-phase aqueous solution; the inner-phase alcohol solution is compressed by the outer-phase aqueous solution to form a laminar flow and diffuses into the aqueous phase to form a narrow mixed solvent region. When the ethanol content in the mixed solvent region is lower than the ethanol content required for the original substances to dissolve in the ethanol phase, the lipids will self-assemble to form liposomes. The liposomes prepared by this invention have a spherical morphology, controllable size, and sustained-release properties in vitro, showing good application prospects as anti-tumor drug carriers in the field of drug delivery.
Owner:CHINA PHARM UNIV

Electroplated layer protective agent and preparation method thereof

The invention relates to an electroplated coating protective agent and a preparation method thereof, and belongs to the technical field of electroplated coating protective agents, and the protective agent comprises the following raw materials: main salt, auxiliary salt, a composite complexing agent, 1-docosanethiol, a sealing agent, absolute ethyl alcohol and deionized water. The succinic acid, the N-sodium lauroyl sarcosinate and the citrazinic acid are used as the composite complexing agent, and starting from different aspects of activating the surface of the coating, accelerating the growth of the protective film layer and increasing the compactness of the protective film layer, the prepared protective agent can effectively improve the corrosion resistance effect of the coating; and the added 1-docosanethiol is used for reducing the defect area of the protective film layer and further effectively improving the corrosion resistance of the protective film. Besides, chromic nitrate is used as a main salt, cerous sulfate and sodium molybdate are used as auxiliary salts, and sodium silicate is used as a sealing agent, so that the prepared protective agent can effectively have remarkable salt spray resistance, and meanwhile, the appearance quality of a formed film layer can also be improved.
Owner:FOSHAN NANHAI DISTRICT AOBO IND & TRADE CO LTD

Preparation method and application of multifunctional layered nanosheet

The invention discloses a preparation method and application of a multifunctional layered nanosheet. The biomimetic hydrogel is prepared through a hydrothermal method, folic acid (FA) is modified on the surface of the biomimetic hydrogel, and the biomimetic hydrogel has the capacity of targeted recognition of pro-inflammatory phenotype macrophages, has the biomimetic activity of multiple enzymes such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and can effectively remove ROS; meanwhile, a succinate dehydrogenase (SDH) inhibitor dimethylmalonic acid (DMM) is loaded in an intercalation mode of the nano material, SDH activity is inhibited in a slow release mode, ROS outbreak caused by mitochondrial reverse electron transfer (RET) is blocked from the source, then a mitochondrial autophagy pathway mediated by BNIP3-LC3B is started, and dynamic and steady state recovery of mitochondria is achieved. The system finally realizes macrophage mitochondrial function reconstruction, oxidation environment improvement and transfer of healthy mitochondria to osteoblasts, so that the osteogenic differentiation capability is recovered, and the effect of treating osteoporosis is achieved.
Owner:YANGZHOU UNIV

Multilayer lutein ester liposome as well as preparation method and application thereof

The invention provides a multilayer lutein ester liposome as well as a preparation method and application thereof, and belongs to the field of food processing. The multi-layer lutein ester liposome is prepared from the following raw materials: 30 to 50 parts of lutein ester, 40 to 60 parts of soybean phosphatidylcholine, 5 to 20 parts of cholesterol, 10 to 25 parts of starch sodium octenylsuccinate, 20 to 40 parts of trehalose, 15 to 30 parts of mannitol, 4 to 10 parts of phosphatidyl glycerol, 1 to 2 parts of vitamin E acetate and 1 to 2 parts of ascorbyl palmitate. According to the present invention, through the specific food-grade raw material composition and the accurate ratio relationship, the comprehensive delivery system is constructed for the highly hydrophobic and unstable lutein ester, and the system synchronously achieves the high encapsulation efficiency, the excellent stability, the good water dispersibility and the slow release function.
Owner:SHENYANG TIANFENG BIOLOGICAL PHARMA

Genetically engineered bacterium of high-yield L-alanine as well as construction method and application of genetically engineered bacterium

ActiveCN120738089ABacteriaMicroorganism based processesPhosphoenolpyruvate carboxylaseSaccharic acid
The invention discloses a genetically engineered bacterium for high yield of L-alanine as well as a construction method and application of the genetically engineered bacterium, a dominant strain is obtained by knocking out an alanine racemase gene dadX and integrating coding sequences of alanine dehydrogenase from different sources, and the shake flask yield is 10.8 g / L; the activity of a corresponding mutant M18L / E75A / A78S / I266V is 4.3 times that of a wild type; 6 by-product related genes are knocked out, meanwhile, a multi-copy strain integrated with alanine dehydrogenase is constructed, and the yield of E.coli A-LB6 in a 5L fermentation tank is increased to 133.3 g / L. Through a dynamic regulation and control strategy, an oxygen-sensitive promoter Pomp * is adopted to replace a phosphoenolpyruvate carboxylase promoter, so that succinic acid byproducts are reduced by 85.8%, and the yield reaches 143.5 g / L after 48 hours of aerobic and anaerobic two-stage fermentation. And finally, by regulating and controlling the ATP synthetase gene cluster atp promoter, the yield of L-alanine in a 50 L fermentation tank reaches 151.3 g / L, and the saccharic acid conversion rate reaches 95.2%. The combination of polygene knockout and dynamic metabolism regulation effectively enhances the biosynthesis ability of alanine, and provides an efficient engineering strain for industrial production.
Owner:ZHEJIANG GARDEN SYNTHETIC BIOLOGY RESEARCH INSTITUTE CO LTD +1

Bio-based succinic acid as well as preparation method and application thereof

The invention provides bio-based succinic acid and a preparation method and application thereof, the median particle size of the bio-based succinic acid is 300-500 [mu] m, and the bio-based succinic acid comprises the following particles in percentage by mass: 0-10% of particles with the particle size of d1, 30-40% of particles with the particle size of d2, 40-50% of particles with the particle size of d3 and 8-18% of particles with the particle size of d4, d1 is less than 150 [mu] m, 150 [mu] m < = d2 < 300 [mu] m, 300 [mu] m < = d3 < 500 [mu] m, and d4 > = 500 [mu] m. The bio-based succinic acid is large in particle size, controllable in particle size distribution and good in uniformity, not only solves the problem of dust raising in succinic acid application, but also can reduce the adhesive force among particles and avoid the problems of agglomeration and caking, so that the storage time of the bio-based succinic acid is prolonged, the succinic acid has proper friction force, and the service life of the bio-based succinic acid is prolonged. The storage performance and the downstream application performance are improved, and the application requirements of various scenes are met.
Owner:SHANGHAI KINGFA SCI & TECH +3

Formulations of apremilast

Provided herein are oral dosage forms comprising a) a core tablet comprising (i) a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion; and (ii) a swellable layer comprising one or more swellable polymers; and b) a coating layer disposed on the core tablet, wherein the oral dosage form surface comprises at least one drug release orifice. The disclosed oral dosage forms provide once-a-day dosing of apremilast and are suitable for treating diseases or disorders ameliorated by inhibiting phosphodiesterase subtype IV (PDE4).
Owner:AMGEN INC

Construction method of escherichia coli mutant for producing succinic acid by fermentation of synthetic culture medium

The invention discloses a construction method of an escherichia coli mutant for producing succinic acid by fermentation of a synthetic medium. The method comprises the following steps: firstly, knocking out a lactic dehydrogenase gene ldhA, a pyruvate formate lyase gene pflB, a ptsG gene responsible for encoding a phosphotransferase system EIIBC protein, an ethanol dehydrogenase gene adhE, an acetokinase-phosphate transacetylase gene ackA-pta, and a ptsG gene responsible for encoding a phosphotransferase system EIIBC protein in escherichia coli; a phosphoenolpyruvate carboxykinase gene pck from bacillus subtilis is integrated at an SS9 safety site of a strain to obtain escherichia coli ESC6 with high succinic acid yield; and mutating one or more loci in one or more genes of a glucose-transcriptional inhibition factor gene mlc, a nitrate response regulatory factor gene narL and a cyclic adenylate receptor protein gene crp to obtain the escherichia coli mutant capable of producing succinic acid by fermentation of a synthetic culture medium, wherein the one or more loci in one or more genes of the glucose-transcriptional inhibition factor gene mlc, the nitrate response regulatory factor gene narL and the cyclic adenylate receptor protein gene crp are mutated. The strain can be fermented in a synthetic medium to produce succinic acid, so that the fermentation cost is greatly reduced, and the strain has a very wide application prospect.
Owner:DALIAN UNIV OF TECH

Gas engine lubricating oil composition and preparation method thereof

PendingCN120924330ALubricant compositionButanedioic acidAlkylphosphate
The invention provides a gas engine lubricating oil composition and a preparation method thereof. The gas engine lubricating oil composition of the present invention comprises: (A) an alkyl phosphate compound; (B) alkylated diphenylamine; (C) a polyisobutylene succinic acid pentaerythritol ester dispersing agent; (D) a salicylate and / or sulfonate; (E) zinc dialkyl dithiophosphate; (F) an oil-soluble organic molybdenum friction modifier; (G) a metal corrosion inhibitor; (H) a pour point depressant; (I) a major amount of a lubricating base oil. The gas engine lubricating oil composition disclosed by the invention has excellent high-temperature oxidation resistance, cleaning performance, extreme pressure anti-wear performance and anti-corrosion performance.
Owner:CHINA PETROLEUM & CHEMICAL CORP +1

High-stability engineered exosome based on rigid hydrophobic anchoring and micelle disassembly and purification as well as preparation method and application of high-stability engineered exosome

The invention relates to the technical field of biomedicine nanotechnology, in particular to a high-stability engineered exosome based on rigid hydrophobic anchoring and micelle disassembly and purification as well as a preparation method and application of the high-stability engineered exosome. According to the invention, a ternary surface structure of rigid hydrophobic anchoring-hydrophilic polymer spacer arm-targeting ligand (L-S-T) is constructed, cholesterol hemisuccinate or multi-branched lipid is selected as an anchoring group, and the problem that conventional phospholipid modification is easy to fall off in vivo and in an albumin-containing preparation is obviously solved; a technology of'micellar insertion after temperature control 'combined with'CMC critical concentration adjustment and purification' is adopted, lossless insertion of functional molecules is realized by utilizing thermodynamic driving force, and residual micelles are induced to be disintegrated into monomers by adjusting the concentration of a system to be lower than the concentration of critical micelles, so that efficient removal of free impurities is realized through conventional ultrafiltration. The engineered exosome has the advantages of long circulation, high targeting and excellent storage stability, and has important clinical application and commercial transformation prospects.
Owner:SHENZHEN HUAAN EXCELLENT HEALTH TECHNOLOGY CO LTD